Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 10,876

Sort by:

Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021 provid...

April 2021 40 pages

Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021 SUMMARY Churg-Strauss Syndrome (Immunology) - Drugs in Development, 2021 provides an overview of the Churg-Strauss Syndrome pipeline la...

April 2021 30 pages

Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Circadian Rhythm Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overvi...

April 2021 35 pages

Cirrhosis (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Cirrhosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Cirrhosis pipeline landscape. The report provide...

April 2021 35 pages

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) (Genetic Disorders) -...

April 2021 30 pages

Claudin 18 (CLDN18) - Drugs in Development, 2021

US$ 3,000.00

Claudin 18 (CLDN18) - Drugs in Development, 2021 SUMMARY Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report p...

April 2021 35 pages

Clostridium difficile Toxin A (toxA or EC 3.4.22.) - Drugs in Development, 2021

US$ 3,000.00

Clostridium difficile Toxin A (toxA or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Clostridium difficile Toxin A (toxA or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on Cl...

April 2021 45 pages

Clostridium difficile Toxin B (toxB or EC 3.4.22.) - Drugs in Development, 2021

US$ 3,000.00

Clostridium difficile Toxin B (toxB or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Clostridium difficile Toxin B (toxB or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on Cl...

April 2021 45 pages

CNS Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

CNS Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY CNS Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the CNS Lymphoma pipeline landscape. The report provides compr...

April 2021 30 pages

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) - Drugs in Development, 2021

US$ 3,000.00

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) - Drugs in Development, 2021 SUMMARY Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin...

April 2021 60 pages

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) - Drugs in Development, 2021

US$ 3,000.00

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) - Drugs in Development, 2021 SUMMARY Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Compon...

April 2021 95 pages

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) - Drugs in Development, 2021

US$ 3,000.00

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) - Drugs in Development, 2021 SUMMARY Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21....

April 2021 60 pages

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021

US$ 3,000.00

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 SUMMARY Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development,...

April 2021 35 pages

Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021 SUMMARY Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Cognitive Impa...

April 2021 75 pages

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) - Drugs in Development, 2021

US$ 3,000.00

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) - Drugs in Development, 2021 SUMMARY Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) - Drugs in Development, 2021 provides in de...

April 2021 35 pages

Colon Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Colon Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Colon Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Colon Carcinoma pipeline landscape. The report provi...

April 2021 75 pages

Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 provides an ov...

April 2021 35 pages

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Community Acquired Methicillin-Resistant Staphylococcus au...

April 2021 30 pages

Complement C1q Subcomponent - Drugs in Development, 2021

US$ 3,000.00

Complement C1q Subcomponent - Drugs in Development, 2021 SUMMARY Complement C1q Subcomponent - Drugs in Development, 2021 provides in depth analysis on Complement C1q Subcomponent targeted pipeline th...

April 2021 30 pages

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021

US$ 3,000.00

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021 SUMMARY Complement C1s Subcomponent (C1 Esterase or Complement Co...

April 2021 40 pages

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) - Drugs in Development, 2021

US$ 3,000.00

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) - Drugs in Development, 2021 SUMMARY Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Prot...

April 2021 50 pages

Complement Factor B (Glycine Rich Beta Glycoprotein or C3/C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) - Drugs in Development, 2021

US$ 3,000.00

Complement Factor B (Glycine Rich Beta Glycoprotein or C3/C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) - Drugs in Development, 2021 SUMMARY Complement Factor B (Glycine Rich Bet...

April 2021 30 pages

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) - Drugs in Development, 2021

US$ 3,000.00

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) - Drugs in Development, 2021 SUMMARY Complement Factor D (C3 Convertase Activator or Adipsin or Pr...

April 2021 50 pages

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021

US$ 3,000.00

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 SUMMARY Complement Factor H (Adrenomedullin Binding Protein or...

April 2021 35 pages

Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021 provides an ov...

April 2021 65 pages

Complicated Skin And Skin Structure Infections (cSSSI) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Complicated Skin And Skin Structure Infections (cSSSI) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Complicated Skin And Skin Structure Infections (cSSSI) (Infectious Disease) - Drugs in...

April 2021 30 pages

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs i...

April 2021 30 pages

Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Congenital Ichthyosis...

April 2021 30 pages

Conjunctivitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Conjunctivitis pipeline landscape. The repor...

April 2021 35 pages

Constipation (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Constipation (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Constipation (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Constipation pipeline landscape. The repor...

April 2021 55 pages

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) - Drugs in Development, 2021

US$ 3,000.00

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) - Drugs in Development, 2021 SUMMARY Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Dise...

April 2021 30 pages

Corneal Graft Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Corneal Graft Rejection pipeline...

April 2021 35 pages

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Developm...

April 2021 80 pages

Coronaviridae Infections (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Coronaviridae Infections (Respiratory) - Drugs in Development, 2021 SUMMARY Coronaviridae Infections (Respiratory) - Drugs in Development, 2021 provides an overview of the Coronaviridae Infections pip...

April 2021 35 pages

Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021 provides...

April 2021 30 pages

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic...

April 2021 30 pages

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) - Drugs in Development, 2021

US$ 3,000.00

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) - Drugs in Development, 2021 SUMMARY Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing...

April 2021 35 pages

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021

US$ 3,000.00

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 SUMMARY CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 provides in depth analysis on CREB Binding P...

April 2021 40 pages

Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Creu...

April 2021 35 pages

Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021

US$ 3,000.00

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 SUMMARY Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 prov...

April 2021 30 pages

Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cryptococcal Men...

April 2021 35 pages

Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Cushing's Syndrome pipel...

April 2021 40 pages

Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 SUMMARY Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an overview of the Cutaneous Lupus Eryt...

April 2021 35 pages

Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Cutaneous T-Cell Lymphoma pipeli...

April 2021 105 pages

Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021

US$ 3,000.00

Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021 SUMMARY Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 D...

April 2021 30 pages

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021

US$ 3,000.00

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 SUMMARY Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 provides in depth analysis on Cyclin Depen...

April 2021 35 pages

Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Drugs in Development, 202...

April 2021 30 pages

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021

US$ 3,000.00

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021 S...

April 2021 30 pages

Cystinuria (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Cystinuria (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Cystinuria (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Cystinuria pipeline landscape. The report pr...

April 2021 30 pages

Filters

Clear all